Hugel Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Hugel Inc
Access all reports
Hugel Inc is a South Korea-based biopharmaceutical company specializing in aesthetic and therapeutic medical products. The company develops, manufactures, and markets botulinum toxin products, dermal fillers, and other medical devices used in cosmetic procedures and treatments. Hugel also provides related services for aesthetic clinics and healthcare providers. Its operations include research and development, regulatory compliance, and international distribution, serving both domestic and overseas markets. The company is headquartered in Gangwon-do, South Korea, and its shares are listed on the KRX.
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
A145020
Country
🇰🇷 South Korea